ATE323475T1 - D-methionin zur reduzierung der toxizität von platin-enthaltenden antitumor verbindungen - Google Patents

D-methionin zur reduzierung der toxizität von platin-enthaltenden antitumor verbindungen

Info

Publication number: ATE323475T1
Authority: AT; Austria
Prior art keywords: platinum; methionine; reducing; toxicity; antitumor compounds
Prior art date: 1996-10-03

Application number

AT97911634T

Other languages

English (en)

Inventor

Kathleen C M Campbell

Original Assignee

Univ Southern Illinois

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-03

Filing date

1997-10-02

Publication date

2006-05-15

1997-10-02 Application filed by Univ Southern Illinois filed Critical Univ Southern Illinois

2006-05-15 Application granted granted Critical

2006-05-15 Publication of ATE323475T1 publication Critical patent/ATE323475T1/de

Links

FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 title abstract 2
230000000259 anti-tumor effect Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
230000001988 toxicity Effects 0.000 title 1
231100000419 toxicity Toxicity 0.000 title 1
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 4
239000002246 antineoplastic agent Substances 0.000 abstract 2
229940127089 cytotoxic agent Drugs 0.000 abstract 2
229910052697 platinum Inorganic materials 0.000 abstract 2
201000004384 Alopecia Diseases 0.000 abstract 1
229930182818 D-methionine Natural products 0.000 abstract 1
206010059024 Gastrointestinal toxicity Diseases 0.000 abstract 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
206010029350 Neurotoxicity Diseases 0.000 abstract 1
206010044221 Toxic encephalopathy Diseases 0.000 abstract 1
231100000360 alopecia Toxicity 0.000 abstract 1
229960004316 cisplatin Drugs 0.000 abstract 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 1
231100000414 gastrointestinal toxicity Toxicity 0.000 abstract 1
229930182817 methionine Natural products 0.000 abstract 1
231100000228 neurotoxicity Toxicity 0.000 abstract 1
230000007135 neurotoxicity Effects 0.000 abstract 1
239000003223 protective agent Substances 0.000 abstract 1
230000004083 survival effect Effects 0.000 abstract 1
230000004580 weight loss Effects 0.000 abstract 1
208000016261 weight loss Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT97911634T 1996-10-03 1997-10-02 D-methionin zur reduzierung der toxizität von platin-enthaltenden antitumor verbindungen ATE323475T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2775096P	1996-10-03	1996-10-03

Publications (1)

Publication Number	Publication Date
ATE323475T1 true ATE323475T1 (de)	2006-05-15

Family

ID=21839569

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97911634T ATE323475T1 (de)	1996-10-03	1997-10-02	D-methionin zur reduzierung der toxizität von platin-enthaltenden antitumor verbindungen

Country Status (10)

Country	Link
EP (1)	EP0930877B1 (de)
JP (1)	JP4260889B2 (de)
AT (1)	ATE323475T1 (de)
AU (1)	AU726392B2 (de)
CA (1)	CA2265983C (de)
DE (1)	DE69735722T2 (de)
DK (1)	DK0930877T3 (de)
ES (1)	ES2263172T3 (de)
PT (1)	PT930877E (de)
WO (1)	WO1998014182A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7071230B2 (en)	1997-10-02	2006-07-04	Board Of Trustees Of Southern Illinois University	Therapeutic use of D-methionine to reduce the toxicity of noise
PL370867A1 (en) *	2001-09-24	2005-05-30	Tosk, Inc.	Reduced toxicity cisplatin formulations and methods for using the same
US20050090551A1 (en) *	2003-10-27	2005-04-28	Board Of Trustees Of Southern Illinois University	Therapeutic use of methionine for the treatment or prevention of mucositis
WO2014134184A1 (en)	2013-02-28	2014-09-04	Anida Pharma Inc.	Methods of treating ototoxicity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE173627T1 (de) *	1992-09-04	1998-12-15	Fuji Chem Ind Co Ltd	Medizinische zusammensetzung

1997
- 1997-10-02 WO PCT/US1997/018114 patent/WO1998014182A1/en not_active Ceased
- 1997-10-02 DE DE69735722T patent/DE69735722T2/de not_active Expired - Lifetime
- 1997-10-02 DK DK97911634T patent/DK0930877T3/da active
- 1997-10-02 ES ES97911634T patent/ES2263172T3/es not_active Expired - Lifetime
- 1997-10-02 AT AT97911634T patent/ATE323475T1/de not_active IP Right Cessation
- 1997-10-02 AU AU48957/97A patent/AU726392B2/en not_active Ceased
- 1997-10-02 EP EP97911634A patent/EP0930877B1/de not_active Expired - Lifetime
- 1997-10-02 PT PT97911634T patent/PT930877E/pt unknown
- 1997-10-02 CA CA002265983A patent/CA2265983C/en not_active Expired - Fee Related
- 1997-10-02 JP JP51697398A patent/JP4260889B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69735722T2 (de)	2007-04-12
WO1998014182A1 (en)	1998-04-09
EP0930877A1 (de)	1999-07-28
CA2265983A1 (en)	1998-04-09
EP0930877B1 (de)	2006-04-19
AU4895797A (en)	1998-04-24
DK0930877T3 (da)	2006-08-21
JP4260889B2 (ja)	2009-04-30
CA2265983C (en)	2003-12-23
JP2001501626A (ja)	2001-02-06
ES2263172T3 (es)	2006-12-01
AU726392B2 (en)	2000-11-09
DE69735722D1 (de)	2006-05-24
PT930877E (pt)	2006-09-29

Similar Documents

Publication	Publication Date	Title
DE69815872D1 (de)	2003-07-31	Verwendung von d-methionin zur verminderung der toxizität von ototoxischen arzneimitteln und geräusch
EP1478406A4 (de)	2006-01-11	Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
CY2473B1 (en)	2005-06-03	New phenanthridines.
DK0612248T3 (da)	2003-12-08	Præparat, der indeholder cisplatin og topotecan som antitumormiddel
CA2294247A1 (en)	1999-01-14	Antioxidant enhancement of therapy for hyperproliferative conditions
IL133824A (en)	2005-12-18	Tetrazole derivatives and medicaments containing the same
IL140710A0 (en)	2002-02-10	Pulmonary delivery of active agents
NO971889D0 (no)	1997-04-24	Forbindelser og sammensetninger for levering av aktive midler
MY117526A (en)	2004-07-31	N-(3-benzofuranyl)urea-derivatives
YU48701A (sh)	2004-05-12	Fenilfenantridini sa dejstvom inhibicije pde-iv
GEP20074099B (en)	2007-05-10	3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
TR199701147T1 (xx)	1998-02-21	Kanserlerin geli�mesini �nlemeye mahsus, benzimidazol i�eren bir farmas�tik bile�im.
GR3026602T3 (en)	1998-07-31	Morphogen-induced liver regeneration.
BG106057A (en)	2002-04-30	Method of enhancing the efficacy of anti-tumour agents
ATE413179T1 (de)	2008-11-15	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
HUP0303838A2 (hu)	2004-03-01	Eritropoietin mérsékli a kemoterápia-indukált toxicitást in vivo
SI1147088T1 (sl)	2006-06-30	6-arilfenantridini s PDE-IV inhibirajoco aktivnostjo
ATE323475T1 (de)	2006-05-15	D-methionin zur reduzierung der toxizität von platin-enthaltenden antitumor verbindungen
GR3035982T3 (en)	2001-08-31	Terpenoidic derivatives (sarcodictyins) useful as antitumor agents
DK0980205T3 (da)	2003-10-20	Anvendelse af en kombination af TALL-104 celler med adriamycin eller cisplatin i behandlingen af maligniteter
DE60133491D1 (de)	2008-05-15	Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung
DE60203895D1 (de)	2005-06-02	Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
PT1135161E (pt)	2005-01-31	Composicao e metodo terapeutico
SI1075476T1 (en)	2003-10-31	Novel benzimidazoles and benzoxazoles
MXPA04006675A (es)	2004-10-04	Composicion farmaceutica que comprende glitazona y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.

Legal Events

Date

Code

Title

Description

2007-02-15

UEP

Publication of translation of european patent specification

Ref document number: 0930877

Country of ref document: EP

2010-07-15

REN

Ceased due to non-payment of the annual fee